Prognostic Factors and Expression of MDM2 in Patients with Primary Extremity Liposarcoma
Open Access
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Management of soft tissue sarcomas (STS) in first isolated local recurrence: a retrospective study of 83 casesRadiotherapy and Oncology, 2004
- Current soft-tissue sarcoma classificationsEuropean Journal of Cancer, 2004
- Evaluation of MDM2 and CDK4 amplification by real‐time PCR on paraffin wax‐embedded material: a potential tool for the diagnosis of atypical lipomatous tumours/well‐differentiated liposarcomasThe Journal of Pathology, 2003
- MDM2 gene amplification in bone and soft‐tissue tumors: Association with tumor progression in differentiated adipose‐tissue tumorsInternational Journal of Cancer, 1995
- MDM2 gene amplification correlates with ring chromosomes in soft tissue tumorsGenes, Chromosomes and Cancer, 1994
- Prognostic Factors Predictive of Survival and Local Recurrence for Extremity Soft Tissue SarcomaAnnals of Surgery, 1994
- Liposarcoma: A population‐based epidemiologic and prognostic study of features of 43 patients, including tumor DNA contentInternational Journal of Cancer, 1993
- The prognostic value of histologic subtypes in primary extremity liposarcomaCancer, 1989
- Prognostic factors for local recurrence and survival in patients with localized extremity soft‐tissue sarcomaSeminars in Surgical Oncology, 1988
- Sarcomas of the Soft TissuesCA: A Cancer Journal for Clinicians, 1961